Prospector Partners LLC Astrazeneca PLC Transaction History

Prospector Partners LLC

$863 Million
Q4 2024

A detailed history of Prospector Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prospector Partners LLC holds 7,055 shares of AZN stock, worth $550,007. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,055

Previous 7,055 -0.0%

Holding current value

$550,007

Previous $549,000 15.85%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $27,217 - $31,105	355 Added 5.3%	7,055 $549,000
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $22,581 - $25,740	370 Added 5.85%	6,700 $453,000
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $27,541 - $30,829	445 Added 7.56%	6,330 $426,000
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $9,751 - $11,746	-175 Reduced 2.89%	5,885 $390,000
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $1.32 Million - $1.58 Million	-27,250 Reduced 81.81%	6,060 $303,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $45,109 - $51,935	-850 Reduced 2.49%	33,310 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $114,215 - $146,571	2,650 Added 8.41%	34,160 $1.81 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $18,517 - $25,151	-490 Reduced 1.53%	31,510 $1.41 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $557,668 - $632,033	-13,900 Reduced 30.28%	32,000 $1.43 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $493,311 - $597,978	-13,900 Reduced 23.24%	45,900 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $434,400 - $510,000	15,000 Added 33.48%	59,800 $2.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	44,800	44,800 $1.53 Million

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.

Account

Prospector Partners LLC Astrazeneca PLC Transaction History